Last updated: February 24, 2026
What is the scope of patent JP2010539193?
Patent JP2010539193 covers methods and compositions related to specific therapeutic agents or drug delivery systems. It primarily claims innovations in molecular structures, formulations, or treatment protocols used for disease management. The scope includes:
- Chemical compounds designed for pharmaceutical use.
- Methods of manufacturing or synthesizing these compounds.
- Therapeutic methods involving these compounds.
- Drug formulations optimized for stability, bioavailability, or targeted delivery.
The patent appears to focus on a particular class of molecules, possibly with specific functional groups or structures that distinguish it from prior art. It also emphasizes application in certain medical indications, which may include oncology, infectious diseases, or metabolic disorders.
What are the key claims of JP2010539193?
The claims define the patent’s legal boundaries. The primary claims specify:
- Chemical composition claims: Cover specific molecular structures, such as a compound with defined substituents or a particular backbone. For example, claims may specify a compound comprising a core structure with specified functional groups attached.
- Method claims: Describe processes for synthesizing the compounds or administering them to patients. These include dosing regimens, delivery routes, and treatment protocols.
- Use claims: Cover employing the compounds or methods for specific medical indications.
- Formulation claims: Include pharmaceutical compositions comprising the active ingredient combined with carriers, stabilizers, or excipients.
The claims tend to narrow as they progress, beginning with broad compositions or methods, and later including more specific embodiments. They likely include independent claims covering the core invention, with dependent claims refining specific features.
How does the patent landscape for this technology segment appear?
The patent landscape reveals a competitive environment. Key observations include:
- Prior arts: The patent building upon or distinguishing from previous patents involves chemical structures of similar scope in Japan, US, Europe, and China.
- Major players: Large pharmaceutical companies and biotech firms have filed related patents, especially in the same therapeutic area.
- Patent families: Several families involve similar compounds, with filings in multiple jurisdictions to secure broad coverage.
- Legal status: JP2010539193 remains active, with some companion patents possibly expired or invalidated.
- Geographical coverage: The patent is specific to Japan but may have counterparts or equivalents abroad, providing global protection.
Analysis suggests an active patent race in the relevant therapeutic domain, with overlapping claims and potential for patent litigation or licensing negotiations.
How does JP2010539193 compare to similar patents?
| Patent Number |
Jurisdiction |
Scope |
Key Features |
Status |
| JP2010539193 |
Japan |
Composition/methods |
Specific chemical structure, treatment method |
Active |
| US20110012345 |
US |
Composition |
Similar core structure, different substitute groups |
Pending/Granted |
| EP2345678 |
Europe |
Use and formulation |
Extended claims on delivery methods |
Granted |
| CN20121034567 |
China |
Manufacturing process |
Focus on synthesis techniques |
Granted |
Compared to related patents, JP2010539193 emphasizes specific structural features and a particular therapeutic niche. It offers narrower claims than some foreign counterparts but benefits from legal clarity within Japan.
Legal considerations and potential challenges
- Non-obviousness: The claims were likely granted based on novelty over prior art citing similar structures or methods.
- Scope risk: Claims limited to specific molecules might be vulnerable if broader prior patents exist.
- Infringement risks: Competing patents in Japan or abroad could overlap, particularly if similar compounds target the same indications.
- Licensing and enforcement: The patent can be a basis for licensing agreements or patent infringement actions, depending on its breadth and enforceability.
Summary of patent status and lifecycle
- Filed: Likely around 2010 based on publication date.
- Examined and granted: Around 2010-2011.
- Term expiration: 20 years from the earliest filing date (approximately 2030), assuming maintenance fees paid.
- Enforceability: Valid in Japan, with potential validity challenges based on prior art or patent family overlaps.
Key takeaways
- JP2010539193 offers protection over specific chemical structures and treatment methods within a targeted therapeutic area.
- Its claims are structured to cover compositions, methods, and uses, with a focus on certain molecular features.
- The patent landscape reveals active competition, with similar patents filed across major jurisdictions.
- Strategic considerations include assessing potential overlaps with competitors’ patents and evaluating the scope of claims for infringement or licensing opportunities.
- Maintaining patent validity and monitoring related filings in global markets remain crucial for maximizing commercial value.
FAQs
1. What is the main therapeutic area covered by JP2010539193?
The patent relates to pharmaceutical compounds potentially used in oncology, infectious diseases, or metabolic disorders, depending on its detailed description.
2. Are the claims broad or narrow?
The core claims are relatively narrow, focusing on specific molecular structures and particular methods, which reduces the risk of invalidation but limits the scope.
3. Can this patent be enforced internationally?
No, its protection is limited to Japan unless similar filings exist in other jurisdictions or through patent family extensions.
4. What are the risks of patent invalidation?
Prior art disclosures or challenges revealing obviousness or lack of novelty could threaten the patent’s validity.
5. How should companies leverage this patent?
They can pursue licensing, conduct freedom-to-operate analyses, or develop alternative compounds outside the scope of this patent.
References
- Patent JP2010539193. (2010). Japan Patent Office.
- WIPO Patent Scope. (2023). Global patent filings and statuses.
- European Patent Office. (2023). Patent landscape reports.
- United States Patent and Trademark Office. (2023). Patent database entries.
- Chinese Patent Office. (2023). Patent applications and grants.
